V. De Pangher

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

Giuseppe Toffoli, Erika Cecchin, Giuseppe Corona et al. · Journal of Clinical Oncology · 2006 · 333 citations · Full text

Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial—An Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)

Gianpiero Fasola, Ornella Belvedere, Marianna Aita et al. · The Oncologist · 2007 · 79 citations · Full text

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial

Adriano Paccagnella, Adolfo Favaretto, Francesco Oniga et al. · Lung Cancer · 2003 · 65 citations

Medicine, Phase Iii Trial, Pathology +6

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

Alessandra Bearz, Renato Talamini, Gilda Rossoni et al. · BMC Research Notes · 2012 · 45 citations · Full text

Carboplatin and gemcitabine chemotherapy for malignant pleural mesothelioma (MPM): a phase II study of the GSTPV

S.M.L. Aversa, C Arcuri, V. De Pangher et al. · Lung Cancer · 1998 · 10 citations

Malignant Pleural Mesothelioma, Medicine, Pathology +6